Agili-C

Land: Israel

Sprache: Hebräisch

Quelle: Ministry of Health

Verfügbar ab:

Cartiheal (2009) Ltd.

Klasse:

בית חולים

Hergestellt von:

Cartiheal (2009) Ltd.

Therapiegruppe:

רופא

Anwendungsgebiete:

Agili-C implant is a bi-phasic, porous resorbable tissue regeneration scaffold for the treatment of focal articular cartilage and/or osteochondral defects. It is indicated for cartilage and/or bone repair. The implant serves as a scaffold for cellular and matrix ingrowth. The Agili-C implant is expected to biodegrade within 6 – 12 months.

Produktbesonderheiten:

Agili-C implant is a bi-phasic, porous resorbable tissue regeneration scaffold for the treatment of focal articular cartilage and/or osteochondral defects. It is indicated for cartilage and/or bone repair. The implant serves as a scaffold for cellular and matrix ingrowth. The Agili-C implant is expected to biodegrade within 6 – 12 months.